推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Pharmacology Research & Perspectives 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
热门AI工具: 论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重 论文讨论生成 参考文献挖掘工具 审稿意见辅助撰写
查看更多AI工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
热
全流程投稿协助套餐服务
热
SCI论文AI润色+人工QC服务
热
Springer Nature特刊征稿

按研究方向查看:


Pharmacology Research & Perspectives期刊基本信息Hello,您是该期刊的第27687位访客

基本信息 登录收藏
期刊名字Pharmacology Research & PerspectivesPharmacology Research & Perspectives

PHARMACOL RES PERSPE
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
4.9
51人评分
我要评分

声誉
5.9

影响力
3.6

速度
6.9

期刊ISSN2052-1707
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
2025-2026最新IF
(数据来源于网友提供)
注册或登录后,查看IF
实时影响因子 截止2026年9月20日:2.321
2025-2026自引率3.8%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
3.101数据由网友[sharpclimber861]收集提供
h-index 暂无h-index数据
CiteScore
( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名
4.500.7420.845
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:General Pharmacology, Toxicology and Pharmaceutics
Q118 / 79
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Neurology
Q287 / 201

期刊简介
PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址
该期刊中国学者近期发文 - NewPreclinical and Toxicology Studies of LPM7100328, a Novel Oral GnRH Antagonist
Author: Wang, Yao; Zhao, Junxian; Zou, Fangxia; Jiang, Wanglin; Zhang, Jianzhao; Yu, Pengfei; Ye, Liang; Sun, Xiaolin; Li, Chunmei; Tian, Jingwei
Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 5, pp. -. DOI: 10.1002/prp2.70312


Multi-Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease
Author: Wei, Yuanyuan; Wei, Dingyi; Lu, Jingyang; Wei, Lulin; Lin, Weijia; Wei, Jinbin; Ma, Xiao
Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70310


Hirudin Attenuates Uric Acid-Induced Renal Tubular Injury via TNFRSF6B-Mediated Suppression of NF-κB Signaling
Author: Zhao, Yingxue; Qin, Yongjie; He, Lanzhi; Luo, Haikun; Mo, Ying; Zhou, Weihai; He, Huamei; Zhou, Ganping; Liu, Xihua
Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70305


Potent and Sustained Lowering of Serum Uric Acid by YJH-012-D, a GalNAc-Conjugated siRNA Targeting Xanthine Dehydrogenase
Author: Tang, Tingke; Li, Qiuying; Zhang, Chenguang; Wang, Yongxing; Yang, Lu; Huang, Haibin; He, Yujun; Zheng, Zhi; Liang, Dong; Wang, Meng; Wu, Yingyu; Zhao, Chengjiang; Cui, Wenhao
Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70308


期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Pharmacology Research & Perspectives的语言要求,还能让Pharmacology Research & Perspectives编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Pharmacology Research & Perspectives编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD3850; GBP2420; EUR2810; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:perspectives、pharmacology、replication studies、target validation
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review
通讯方式THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ
出版商Wiley-Blackwell
涉及的研究方向Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
出版国家或地区ENGLAND
出版语言English
出版周期
出版年份0
年文章数 145点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比:
文章 ÷(文章 + 综述)
84.83%
WOS期刊JCR分区
( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
( 2026年3月发布)
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 4区3区2区
PHARMACOLOGY & PHARMACY
药学
2区2区3区
否N/A
期刊分区表
( 2025年3月升级版)
大类学科小类学科Top期刊综述期刊
医学 2区4区4区
PHARMACOLOGY & PHARMACY
药学
4区2区3区
否否
期刊分区表
( 2023年12月旧的升级版)
大类学科小类学科Top期刊综述期刊
医学 3区4区3区
PHARMACOLOGY & PHARMACY
药学
2区4区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2052-1707%5BISSN%5D
平均审稿速度网友分享经验:
20 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( USD3850; GBP2420; EUR2810; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Pharmacology Research & Perspectives顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。
提交文稿
期刊常用信息链接
同领域相关期刊 Pharmacology Research & Perspectives期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Pharmacology Research & Perspectives期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Pharmacology Research & Perspectives上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Acta Pharmaceutica Sinica B2824.40
    Antibiotics-Basel010.20
    Therapeutics and Clinical Risk Management03.70
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy373.30
    Pharmacological Research Modern Chinese Medicine05.70
    Mental Health Clinician02.10
    Infarma Pharmaceutical Sciences00.10
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE925283
    JOURNAL OF ETHNOPHARMACOLOGY825888
    Frontiers in Immunology778960
    BIOMEDICINE & PHARMACOTHERAPY744137
    Frontiers in Pharmacology742218
    BIOMATERIALS732567
    PHYTOMEDICINE671526
    Frontiers in Oncology639279
    Biomedical Signal Processing and Control630120
    IEEE Journal of Biomedical and Health Informatics621573
  •  

    Pharmacology Research & Perspectives Pharmacology Research & Perspectives
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Preclinical and Toxicology Studies of LPM7100328, a Novel Oral GnRH Antagonist

    Author: Wang, Yao; Zhao, Junxian; Zou, Fangxia; Jiang, Wanglin; Zhang, Jianzhao; Yu, Pengfei; Ye, Liang; Sun, Xiaolin; Li, Chunmei; Tian, Jingwei
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 5, pp. -. DOI: 10.1002/prp2.70312
        PubMed      DOI
    2.Multi-Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease

    Author: Wei, Yuanyuan; Wei, Dingyi; Lu, Jingyang; Wei, Lulin; Lin, Weijia; Wei, Jinbin; Ma, Xiao
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70310
        PubMed      DOI
    3.Hirudin Attenuates Uric Acid-Induced Renal Tubular Injury via TNFRSF6B-Mediated Suppression of NF-κB Signaling

    Author: Zhao, Yingxue; Qin, Yongjie; He, Lanzhi; Luo, Haikun; Mo, Ying; Zhou, Weihai; He, Huamei; Zhou, Ganping; Liu, Xihua
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70305
        PubMed      DOI
    4.Potent and Sustained Lowering of Serum Uric Acid by YJH-012-D, a GalNAc-Conjugated siRNA Targeting Xanthine Dehydrogenase

    Author: Tang, Tingke; Li, Qiuying; Zhang, Chenguang; Wang, Yongxing; Yang, Lu; Huang, Haibin; He, Yujun; Zheng, Zhi; Liang, Dong; Wang, Meng; Wu, Yingyu; Zhao, Chengjiang; Cui, Wenhao
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70308
        PubMed      DOI
    5.Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence

    Author: Belancic, Andrej; Skelin, Marko; Lam, Yun Wah; Fajkic, Almir; Perkov-Stipicin, Bruna; Roncato, Rossana; Krecak, Ivan; Lucijanic, Marko
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70302
        PubMed      DOI
    6.Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases

    Author: Nie, Tailei; Liu, Hongyu; Cheng, Chuanxu; Li, Jian; Lu, Jiajing
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70303
        PubMed      DOI
    7.Development and Validation of an XGBoost-SHAP Model for Predicting Adverse Outcomes in Elderly Cardiovascular Patients With Polypharmacy: A Retrospective Cohort Study

    Author: Wang, Kun; Cao, Dandan
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70293
        PubMed      DOI
    8.Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies

    Author: Hao, Yujinpeng; Shao, Jun; Lian, Naqi; Bian, Mianli
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.1002/prp2.70292
        PubMed      DOI
    9.A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese Subjects

    Author: Yang, Ying; Han, Mai; Cui, Gang; Zhang, Dan; Wu, Wei; Mi, Na; Jin, Jiangli; Zhang, Shuxiao; Zhang, Xin; Li, Junjie; Xiao, Chunyan; Wang, Jing; Gou, Chaoyun; Su, Chong; Li, Jintong
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1002/prp2.70277
        PubMed      DOI
    10.A Prospective Study of Marsh PK-PD Model and Schnider PK-PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery

    Author: Ye, Jianhong; Liang, Weina
    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.1002/prp2.70284
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    Foundations and Trends in Computer Graphics and Vision032.80
    PROGRESS IN REACTION KINETICS AND MECHANISM2321.60
    Journal of Obesity & Metabolic Syndrome014.40
    Advanced Sensor and Energy Materials03.70
    Business & Information Systems Engineering018.50
    Business & Information Systems Engineering018.50
    Battery Energy015.10
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM425.50
    PROGRESS IN PHOTOVOLTAICS11518.50
    Degenerative Neurological and Neuromuscular Disease00.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共1条


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室